Biocon Sets Price Band for Clinical Services Arm Syngene's IPO

Syngene\'s IPO shall open for subscription on July 27 and close on July 29, Biocon said in a filing to exchanges.

Published: 16th July 2015 08:43 AM  |   Last Updated: 16th July 2015 08:43 AM   |  A+A-

MUMBAI: Drugmaker Biocon Ltd <BION.NS> has set the price band for an initial public offering (IPO) of its clinical research services arm, Syngene International Ltd, at 240 rupees to 250 rupees a share, it said on Thursday.

Syngene's IPO shall open for subscription on July 27 and close on July 29, Biocon said in a filing to exchanges.

Biocon said in April that it planned to sell 22 million shares and provide an overallotment option. ($1 = 62.9100 rupees)

Stay up to date on all the latest Business news with The New Indian Express App. Download now
(Get the news that matters from New Indian Express on WhatsApp. Click this link and hit 'Click to Subscribe'. Follow the instructions after that.)

Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp